{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:11:59Z","timestamp":1784139119203,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.urolonc.2007.12.011","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T12:34:30Z","timestamp":1209472470000},"page":"258-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-G\u00faerin immunotherapy"],"prefix":"10.1016","volume":"27","author":[{"given":"Ofer N.","family":"Gofrit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Pode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Pizov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mordechi","family":"Duvdevani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2007.12.011_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0094-0143(05)70197-X","article-title":"Diagnosis and grading of bladder cancer and associated lesions","volume":"26","author":"Bostwick","year":"1999","journal-title":"Urol Clin North Am"},{"issue":"1","key":"10.1016\/j.urolonc.2007.12.011_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000474878","article-title":"Morphometric and immunohistochemical characterization of bladder carcinoma in situ and its preneoplastic lesions","volume":"21","author":"Sanchez-Fernandez de Sevilla","year":"1992","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/1097-0142(19820801)50:3<515::AID-CNCR2820500323>3.0.CO;2-Q","article-title":"The origin of invasive carcinoma of the bladder","volume":"50","author":"Brawn","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2007.12.011_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0094-0143(05)70229-9","article-title":"The natural history of bladder cancer","volume":"27","author":"Lee","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2007.12.011_bib5","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199411103311903","article-title":"Accumulation of nuclear p53 and tumor progression in bladder cancer","volume":"331","author":"Esrig","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2007.12.011_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(17)59645-7","article-title":"The clinical significance of carcinoma in situ of the bladder and its association with overt carcinoma","volume":"112","author":"Skinner","year":"1974","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.1974.03230160009002","article-title":"Mapping cancerous and precancerous bladder changes","volume":"227","author":"Koss","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2007.12.011_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-5347(17)58916-8","article-title":"Noninvasive papillary carcinoma of the bladder associated with carcinoma in situ","volume":"116","author":"Althausen","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0022-5347(01)67650-X","article-title":"Carcinoma in situ of the bladder","volume":"153","author":"Hudson","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-G\u00faerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2007.12.011_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.ju.0000150425.09317.67","article-title":"Bacillus Calmette-G\u00faerin vs. epirubicin for primary, secondary, or concurrent carcinoma in situ of the bladder: Results of a European Organization for the Research and Treatment of Cancer, Genito-Urinary Group, Phase III trial (30906)","volume":"173","author":"de Reijke","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ju.0000162059.64886.1c","article-title":"Bacillus Calmette-Gu\u00e9rin vs. chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder","volume":"174","author":"Sylvester","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-5347(17)37452-9","article-title":"Bacillus Calmette-G\u00faerin therapy for superficial bladder cancer","volume":"147","author":"Herr","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1097-0142(19830801)52:3<524::AID-CNCR2820520324>3.0.CO;2-C","article-title":"Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms","volume":"52","author":"Prout","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2007.12.011_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/1097-0142(19940701)74:1<115::AID-CNCR2820740120>3.0.CO;2-R","article-title":"Carcinoma in situ of the urinary bladder","volume":"74","author":"Orozco","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2007.12.011_bib16","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","article-title":"Survival of patients with carcinoma in situ of the urinary bladder","volume":"85","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2007.12.011_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000049765","article-title":"Intravesical BCG in patients with carcinoma in situ of the urinary bladder: Long-term results of EORTC GU Group Phase II protocol 30861","volume":"40","author":"Jakse","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-5347(17)40575-1","article-title":"Superficial bladder cancer treated with bacillus Calmette-G\u00faerin: A multivariate analysis of factors affecting tumor progression","volume":"141","author":"Herr","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib19","series-title":"International histological classification of tumors, No 10","author":"Mostofi","year":"1973"},{"key":"10.1016\/j.urolonc.2007.12.011_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(17)45091-9","article-title":"Two courses of intravesical bacillus Calmette-G\u00faerin for transitional cell carcinoma of the bladder","volume":"136","author":"Haaff","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-5347(17)39544-7","article-title":"The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS, and P2)","volume":"144","author":"Malkowicz","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1464-410X.1988.tb13967.x","article-title":"Chemotherapy for carcinoma in situ of the bladder","volume":"61","author":"Jenkins","year":"1988","journal-title":"Br J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0302-2838(03)00140-4","article-title":"Alternating mitomycin C and BCG instillations vs. BCG alone in treatment of carcinoma in situ of the urinary bladder: A Nordic study","volume":"43","author":"Kaasinen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1464-410X.1995.tb07307.x","article-title":"Analysis of early failures after intravesical instillation therapy with bacille Calmette-G\u00faerin for carcinoma in situ of the bladder","volume":"75","author":"Merz","year":"1995","journal-title":"Br J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib25","first-page":"4079","article-title":"Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence","volume":"5","author":"Pfister","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2007.12.011_bib26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/cncr.22588","article-title":"PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: Associations with localized stage progression","volume":"109","author":"Inman","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2007.12.011_bib27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-G\u00faerin immunotherapy for recurrent TA, T1, and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.12.011_bib28","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-G\u00faerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143907003328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143907003328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:55:35Z","timestamp":1761040535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143907003328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1078143907003328"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2007.12.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-G\u00faerin immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2007.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}